About Bilcare
Bilcare is a company based in Pune (India) founded in 1993 by Mohan Bhandari was acquired by Lindsay Goldberg in September 2019. The company has 78 employees as of March 31, 2024. Bilcare has completed 1 acquisition, including Singular ID. Bilcare offers products and services including Blister Films, Blister Foils, Lidding Foils, Aluminum Foils, and Polymer Films. Bilcare operates in a competitive market with competitors including Unither, Akums, Jubilant Life Sciences, Recipharm and CoreRx, among others.
- Headquarter Pune, India
- Employees 78 as on 31 Mar, 2024
- Founders Mohan Bhandari
- Stage Public
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Bilcare Ltd
-
Annual Revenue
$91.82 M (USD)5.36as on Mar 31, 2024
-
Net Profit
-$3.36 M (USD)13.36as on Mar 31, 2024
-
EBITDA
$5.21 M (USD)13.73as on Mar 31, 2024
-
Latest Funding Round
$116.1 M (USD), Debt – Conventional
Aug 27, 2014
-
Investors
ISM Capital
& 2 more
-
Employee Count
78
as on Mar 31, 2024
- Investments & Acquisitions
-
Acquired by
Lindsay Goldberg
(Sep 04, 2019)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Bilcare
Bilcare is a publicly listed company on the BSE with ticker symbol BI in India, operating in the Process industries sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Products & Services of Bilcare
Bilcare offers a comprehensive portfolio of products and services, including Blister Films, Blister Foils, Lidding Foils, Aluminum Foils, and Polymer Films.
Materials for pharmaceutical blister packaging protection.
Foils used in drug packaging for barrier properties.
Sealing foils for pharmaceutical containers.
Foils providing protection against counterfeiting.
Films for innovative and sustainable packaging solutions.
People of Bilcare
Unlock access to complete
Funding Insights of Bilcare
- Total Funding Total Funding
- Total Rounds 2
- Last Round Debt – Conventional — $116.1M
-
First Round
First Round
(22 Feb 2010)
- Investors Count 2
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Aug, 2014 | Amount | Debt – Conventional - Bilcare | Valuation |
investors |
|
| Feb, 2010 | Amount | Post-IPO - Bilcare | Valuation |
investors |
Investors in Bilcare
Bilcare has secured backing from 3 investors, including venture fund and institutional investors. Prominent investors backing the company include ISM Capital, Proventus and Lindsay Goldberg.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
A family office is operated across Nordic and European regions.
|
Founded Year | Domain | Location | |
|
PE firm invests in the US
|
Founded Year | Domain | Location | |
|
Financial solutions are provided for the investment industry.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Bilcare
Bilcare has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Singular ID.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Unique identification services are provided since 2004 in Singapore.
|
2004 |
Financial Statements - Bilcare
Bilcare Comparisons
Competitors of Bilcare
Bilcare operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Unither, Akums, Jubilant Life Sciences, Recipharm and CoreRx, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Contract development and manufacturing organization for proprietary and generic drugs
|
|
| domain | founded_year | HQ Location |
CDMO focusing on spectrum of dosage forms and therapeutic segments
|
|
| domain | founded_year | HQ Location |
Company offering a suite of R&D and manufacturing services for small molecules and generics
|
|
| domain | founded_year | HQ Location |
Pharmaceutical development and manufacturing services are offered contractually.
|
|
| domain | founded_year | HQ Location |
CDMO with a focus on early phase drug product development
|
|
| domain | founded_year | HQ Location |
Cephalosporin APIs and generic formulations are manufactured.
|
Frequently Asked Questions about Bilcare
Bilcare was founded in 1993 and raised its 1st funding round 17 years after it was founded.
Bilcare is headquartered in Pune, India. It is registered at Pune, Maharashtra, India.
Mohan Bhandari is the current CEO of Bilcare. They have also founded this company.
As of Mar 31, 2024, the latest employee count at Bilcare is 78.
Annual revenue of Bilcare is $91.82M as on Mar 31, 2024.
Bilcare is a pharma packaging solutions provider. The company has 3 major divisions - Pharmaceutical Packaging International (PPI), Global Clinical Material Supplies (GCS) and non-clonable ID technologies. The PPI division offers packaging solutions mainly for solid dose packaging through specialty Polymer Films and Aluminum Foils. The GCS division offers clinical trial supply management services such as clinical supplies packaging and labelling, controlled-temperature (cold chain) CTM storage, worldwide distribution and returns and destructions accountability etc. The non-clonable ID technologies division offers track and trace, authentication and Anti-counterfeit (trademarked nCID technology - nonclonableID) solutions for product; people ID authentication and security. The company has 9 manufacturing facilities spread across Europe, US and Asia. Bilcares clientele includes Bristol-Myers Squibb, Dr. Reddys, GlaxoSmithKline, Johnson Johnson, Merck, Novartis, Pfizer, Ranbaxy, Sanofi-Aventis, and Teva, among others.
Bilcare's top competitors include Jubilant Life Sciences, Akums and Nectar Lifesciences.
Bilcare offers Blister Films, Blister Foils, Lidding Foils, Aluminum Foils, and Polymer Films.
Yes, Bilcare is publicly traded on BSE under the ticker symbol BI.
Bilcare has made 1 acquisition, including Singular ID.
Bilcare has 3 investors. Key investors include ISM Capital, Proventus, and Lindsay Goldberg.
The ticker symbol of Bilcare is BI on BSE.